NCT01841723 2026-03-18
Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
103 trialsNCT05828082 2026-03-18
Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT07112053 2026-03-09
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
University of Washington
Phase 2 Recruiting
NCT06647953 2026-02-24
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Children's Oncology Group
Phase 3 Recruiting
NCT05549661 2026-02-23
Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
Mayo Clinic
Phase 1 Recruiting
NCT07281547 2026-02-18
Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain
Mayo Clinic
Phase 4 Not yet recruiting
NCT04715958 2026-02-17
Prediction of Neoadjuvant Chemotherapy Response Using Contrast-Enhanced Ultrasound in Patients With Locally Advanced Breast Cancer
Thomas Jefferson University
Phase 2/3 Recruiting
NCT06999798 2026-02-12
An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial
Mayo Clinic
Phase 1 Recruiting
NCT04275661 2026-02-04
Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer Surgery
Assiut University
Phase 2 Completed
NCT06876714 2026-02-04
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT06411795 2026-02-03
Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
Masonic Cancer Center, University of Minnesota
Phase 2 Recruiting
NCT06440850 2026-02-02
Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
City of Hope Medical Center
Phase 2 Recruiting
NCT02897427 2026-01-26
TRINITY
Baylor College of Medicine
Active not recruiting
NCT04251052 2026-01-14
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NRG Oncology
Phase NA Recruiting
NCT05989828 2026-01-14
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
University of Southern California
Phase 1 Suspended
NCT05408260 2026-01-05
A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer
Thomas Jefferson University
Phase NA Completed
NCT02176967 2025-12-22
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Children's Oncology Group
Phase 3 Active not recruiting
NCT06635980 2025-12-12
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
Mayo Clinic
Phase 2 Recruiting
NCT00987428 2025-11-20
EEPAB2
Assistance Publique - Hôpitaux de Paris
Phase NA Terminated
NCT04329065 2025-11-06
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer
University of Washington
Phase 2 Recruiting
NCT07016399 2025-10-30
Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC
Vanderbilt-Ingram Cancer Center
Phase 2 Recruiting
NCT05547347 2025-10-27
Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer
Mayo Clinic
Suspended
NCT00210223 2025-10-01
RF-SEIN
Institut Bergonié
Phase NA Completed
NCT00874458 2025-09-30
MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ
Centre Antoine Lacassagne
Phase NA Completed
NCT04537871 2025-09-25
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
City of Hope Medical Center
Active not recruiting
NCT03672331 2025-09-18
MyPeBS
UNICANCER
Phase NA Active not recruiting
NCT03841149 2025-09-15
VolUS3D
Assistance Publique - Hôpitaux de Paris
Completed
NCT05919108 2025-09-09
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
Vanderbilt-Ingram Cancer Center
Phase 2 Recruiting
NCT05336786 2025-09-04
Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)
Thomas Jefferson University
Phase 3 Active not recruiting
NCT07120529 2025-08-13
MOOSE
Medical University of Silesia
Recruiting
NCT02276443 2025-08-01
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT01696994 2025-07-23
Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)
National Cancer Institute (NCI)
Phase NA Active not recruiting
NCT07016737 2025-06-12
ESO-Nanjing12
Jiangsu Cancer Institute & Hospital
Phase 3 Enrolling by invitation
NCT07005089 2025-06-05
Diagnostic Accuracy of Ultrasound and Tumors Markers in Diagnosis of Complex Ovarian Cysts
Al-Azhar University
Phase NA Completed
NCT04185337 2025-02-27
Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT06324721 2025-01-29
LymphSens
Universitaire Ziekenhuizen KU Leuven
Phase NA Recruiting
NCT03982082 2025-01-15
Ultrasound in Evaluating Muscle-Glycogen Content in Cancer Patients
M.D. Anderson Cancer Center
Phase NA Completed
NCT03821376 2024-10-10
Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS)
Indiana University
Phase 4 Terminated
NCT02700230 2024-09-27
Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery
Mayo Clinic
Phase 1 Completed
NCT00655655 2024-08-21
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Mayo Clinic
Phase 1 Completed
NCT03278925 2024-08-02
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT01516710 2024-05-10
Oslo-CoMet
Oslo University Hospital
Phase NA Unknown
NCT02734823 2024-03-18
Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor
University of Southern California
Withdrawn
NCT03414905 2024-02-20
Management of Malignant Pleural Effusions Using an Indwelling Tunneled Pleural Catheter and Non-Vacuum Collection System
Washington University School of Medicine
Completed
NCT04721886 2024-02-15
Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer
Thomas Jefferson University
Phase EARLY_PHASE1 Unknown
NCT01013025 2024-01-02
Vantas Implant Retrieval Study
Endo Pharmaceuticals
Completed
NCT00665457 2023-09-13
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
University of Nebraska
Phase 2 Terminated
NCT05977764 2023-08-04
Multimodal Ultrasound and Focal Liver Lesions (FLLs)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Unknown
NCT02501980 2023-07-13
HCC
Zhongshan People's Hospital, Guangdong, China
Unknown
NCT00881361 2023-04-27
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed